AxoGen, Inc. (AXGN)
NASDAQ·Healthcare·Medical - Devices
$41.71
+5.89%
Mkt Cap $1.86B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 24, 2026 | $59.03M | $59.90M | +1.48% | $0.09 | $0.07 | -21.16% | — | — |
| Q4 2025 Oct 29, 2025 | $59.90M | $60.08M | +0.30% | $0.09 | $0.12 | +33.33% | — | — |
| Q3 2025 Aug 5, 2025 | $56.89M | $56.66M | -0.40% | $0.06 | $0.12 | +100.00% | — | — |
| Q2 2025 May 8, 2025 | $53.34M | $48.56M | -8.97% | -$0.01 | -$0.02 | -100.00% | — | — |
| Q1 2025 Feb 25, 2025 | $48.28M | $49.41M | +2.33% | $0.04 | $0.08 | +100.00% | — | — |
| Q4 2024 Nov 7, 2024 | $47.44M | $48.64M | +2.53% | $0.01 | $0.07 | +1066.67% | — | — |
| Q3 2024 Aug 8, 2024 | $43.39M | $47.91M | +10.42% | -$0.05 | $0.05 | +200.00% | — | — |
| Q2 2024 May 2, 2024 | $43.39M | $41.38M | -4.64% | -$0.10 | -$0.06 | +40.00% | — | — |
| Q1 2024 Mar 5, 2024 | $41.65M | $42.92M | +3.05% | -$0.09 | -$0.06 | +33.33% | — | — |
| Q4 2023 Nov 7, 2023 | $40.68M | $41.27M | +1.45% | -$0.08 | $0.01 | +112.50% | — | — |
| Q3 2023 Aug 7, 2023 | $39.08M | $38.16M | -2.37% | -$0.15 | -$0.03 | +80.00% | — | — |
| Q2 2023 May 9, 2023 | $35.37M | $36.66M | +3.66% | -$0.15 | -$0.10 | +33.33% | — | — |
| Q1 2023 Mar 14, 2023 | $36.20M | $36.16M | -0.10% | -$0.10 | -$0.03 | +70.00% | — | — |
| Q4 2022 Nov 8, 2022 | $36.20M | $36.96M | +2.09% | -$0.15 | -$0.01 | +93.33% | — | — |
| Q3 2022 Aug 3, 2022 | $33.82M | $34.45M | +1.87% | -$0.15 | -$0.06 | +60.00% | — | — |
| Q2 2022 May 4, 2022 | $30.33M | $31.01M | +2.22% | -$0.17 | -$0.20 | -17.65% | — | — |
| Q1 2022 Feb 22, 2022 | $31.79M | $31.54M | -0.80% | -$0.13 | -$0.08 | +38.46% | — | — |
| Q4 2021 Nov 3, 2021 | $34.65M | $31.20M | -9.95% | -$0.12 | -$0.09 | +25.00% | — | — |
| Q3 2021 Aug 4, 2021 | $33.58M | $33.58M | +0.00% | -$0.12 | -$0.09 | +25.00% | — | — |
| Q2 2021 May 5, 2021 | $41.90M | $31.04M | -25.93% | -$0.17 | -$0.08 | +52.94% | — | — |